Influenza Hemagglutinin (HA) Peptide: High-Purity Epitope Tag for Protein Detection and Purification

Executive Summary: The Influenza Hemagglutinin (HA) Peptide (sequence: YPYDVPDYA) is a synthetic, nine-amino acid tag widely used for protein detection and purification in molecular biology [product]. It enables competitive binding to anti-HA antibodies, facilitating efficient elution of HA-tagged fusion proteins during immunoprecipitation [DOI]. The peptide exhibits high solubility in DMSO (≥55.1 mg/mL), ethanol (≥100.4 mg/mL), and water (≥46.2 mg/mL), supporting diverse assay conditions. APExBIO ensures batch-to-batch consistency with >98% purity confirmed by HPLC and mass spectrometry. Its utility extends from classical immunoassays to advanced protein-protein interaction studies and quantitative proteomics.

Biological Rationale

The HA tag peptide derives from the influenza virus hemagglutinin protein, a surface glycoprotein essential for viral entry into host cells [1]. As an epitope tag, YPYDVPDYA is not found in most eukaryotic or prokaryotic proteomes, minimizing cross-reactivity and background in detection assays. The tag is genetically fused to target proteins, allowing their identification or purification using anti-HA antibodies [2]. This approach is foundational in molecular biology, enabling selective isolation of recombinant proteins from complex mixtures without altering their function or structure.

Mechanism of Action of Influenza Hemagglutinin (HA) Peptide

The HA tag peptide functions as a competitive binding ligand for anti-HA monoclonal antibodies [product]. When introduced into an immunoprecipitation workflow, free HA peptide displaces HA-tagged fusion proteins from immobilized antibodies, enabling gentle, specific elution. This mechanism is widely exploited in immunoprecipitation (IP), co-immunoprecipitation (co-IP), and chromatin immunoprecipitation (ChIP) assays [3]. The peptide's small size (1.1 kDa) ensures rapid diffusion and minimal steric hindrance. Its high affinity for anti-HA antibodies (typically <10 nM Kd) underpins the sensitivity and selectivity of HA-based detection and purification protocols.

Evidence & Benchmarks

• HA tag (YPYDVPDYA) enables detection and immunoprecipitation of HA-fusion proteins with minimal background in human, mouse, and yeast cell lysates (Dong et al., 2025, DOI:10.1002/advs.202504704).
• The competitive elution of HA-tagged proteins by synthetic HA peptide is effective at 100–500 μg/mL in standard IP buffer (pH 7.4, 4°C, 30 min) (APExBIO product data).
• Batch-to-batch purity is confirmed at >98% by HPLC/MS, ensuring reproducibility in quantitative proteomics (see internal review).
• HA tag does not interfere with the activity or localization of most fusion partners, as validated in more than 1000 peer-reviewed studies (Dong et al., 2025, DOI).
• Peptide solubility is ≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol, and ≥46.2 mg/mL in water at 25°C (APExBIO).

Applications, Limits & Misconceptions

The Influenza Hemagglutinin (HA) Peptide is a cornerstone in molecular biology for the following applications:

• Immunoprecipitation and co-immunoprecipitation of HA-tagged proteins.
• Competitive elution of fusion proteins from anti-HA antibody matrices.
• Protein-protein interaction mapping and quantitative proteomics.
• Western blot and immunofluorescence detection using anti-HA antibodies.
• Chromatin immunoprecipitation (ChIP) for epigenetic profiling of HA-tagged factors.

This article extends the mechanistic details reviewed in "Influenza Hemagglutinin (HA) Peptide: Precision Tag for Protein Detection" by providing quantitative benchmarks for elution, and clarifies storage parameters for maximal activity.

Common Pitfalls or Misconceptions

• The HA peptide tag does not confer affinity for non-HA antibodies; cross-reactivity is rare but possible with poorly characterized reagents.
• Long-term storage of HA peptide solutions (>1 week) at room temperature or 4°C leads to degradation; always store desiccated at -20°C.
• The HA tag sequence (YPYDVPDYA) must be exposed and accessible on the fusion protein's surface for effective antibody recognition.
• Excessive peptide concentrations (>1 mg/mL) in elution buffers may cause non-specific protein dissociation under some conditions.
• Not all antibodies labeled as "anti-HA" have equivalent affinity or specificity; validation is recommended for each lot and source.

Workflow Integration & Parameters

Integrating the HA peptide into immunoprecipitation or purification workflows is straightforward. Add the peptide (final: 100–500 μg/mL) to the antibody-bound resin after binding and washing steps. Incubate for 20–60 minutes at 4°C. Eluted fractions can be analyzed by SDS-PAGE, mass spectrometry, or functional assays. For optimal storage, keep the lyophilized peptide desiccated at -20°C; avoid repeated freeze-thaw cycles. For detailed integration strategies and troubleshooting, see "Driving Translational Discovery", which this article updates with new purity and solubility standards.

For advanced applications such as exosome biogenesis or signaling pathway analysis, the HA tag enables precise, competitive isolation of low-abundance complexes without harsh denaturants (see also mechanistic insights for further discussion of protein–protein interaction workflows).

Conclusion & Outlook

The Influenza Hemagglutinin (HA) Peptide (A6004) from APExBIO represents a rigorously validated, high-purity reagent for sensitive detection, purification, and elution of HA-tagged proteins. Its robust physical properties, proven antibody compatibility, and consistent batch quality support advanced molecular and translational research. As new applications in proteomics and cancer mechanistic studies emerge, standardized, high-purity HA peptide will remain pivotal for reproducible, high-sensitivity workflows [Dong et al., 2025].